Functional Dyspepsia (Evidences in Pathophysiology and Treatment) || Ghrelin and Functional Dyspepsia
- 作者Tominaga, Kazunari; Kusunoki, Hiroaki
- 文件大小351.84KB
- 发表时间2018
- DOI10.1007/978-981-13-1074-4_8
- 页码91-103
Development of Antibody-Based Therapeutics ||Tabrizi, Mohammad A.; Bornstein, Gadi G.; Klakamp, Scott L. · 2012
Development of Antibody-Based Therapeutics (Translational Considerations & Challenges) || IntroductionTabrizi, Mohammad A.; Bornstein, Gadi G.; Klakamp, Scott L. · 2018
Development of Antibody-Based Therapeutics || Technologies for the Generation of Human AntibodiesTabrizi, Mohammad A.; Bornstein, Gadi G.; Klakamp, Scott L. · 2012
Development of Antibody-Based Therapeutics (Translational Considerations & Challenges) || Epitope Characterization and Isotype SelectionTabrizi, Mohammad A.; Bornstein, Gadi G.; Klakamp, Scott L. · 2018
Development of Antibody-Based Therapeutics (Translational Considerations & Challenges) || Antibody Drug Conjugates: Translational ConsiderationsTabrizi, Mohammad A.; Bornstein, Gadi G.; Klakamp, Scott L. · 2018
Development of Antibody-Based Therapeutics (Translational Considerations & Challenges) || Translational Considerations and Challenges: An OverviewTabrizi, Mohammad A.; Bornstein, Gadi G.; Klakamp, Scott L. · 2018
Development of Antibody-Based Therapeutics (Translational Considerations & Challenges) || Stimulus-Response Mechanisms: An OverviewTabrizi, Mohammad A.; Bornstein, Gadi G.; Klakamp, Scott L. · 2018
Development of Antibody-Based Therapeutics (Translational Considerations & Challenges) || Considerations for Construct and Affinity Design GoalsTabrizi, Mohammad A.; Bornstein, Gadi G.; Klakamp, Scott L. · 2018